Surface design of photon-upconversion nanoparticles for high-contrast immunocytochemistry

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Diagnostics

Background:

• Immunohistochemistry (IHC) and immunocytochemistry (ICC) are standard methods for cancer cell identification.
• Conventional staining techniques suffer from low contrast, limiting diagnostic accuracy.
• Photon-upconversion nanoparticles (UCNP) offer a solution to optical background interference.

Purpose of the Study:

• To develop highly specific UCNP-based nanoconjugates for detecting the cancer biomarker HER2.
• To improve signal-to-background ratios in immunolabeling for breast cancer cell lines.
• To reduce non-specific binding of labels in histological samples.

Main Methods:

• Design and characterization of several UCNP-based nanoconjugates.
• Utilizing streptavidin-PEG-neridronate-UCNP for HER2 detection in breast cancer cell lines.
• Comparison of UCNP labeling with conventional fluorescent labeling techniques.

Main Results:

• An optimized streptavidin-PEG-neridronate-UCNP conjugate achieved a signal-to-background ratio of 319.
• This represents a 50-fold improvement over conventional fluorescent labeling.
• Demonstrated elimination of optical interference and non-specific binding.

Conclusions:

• UCNP-based nanoconjugates provide superior specificity and contrast for cancer biomarker detection.
• The developed method significantly enhances signal-to-background ratios, outperforming traditional methods.
• This approach enables reliable computer-based data evaluation for digital pathology.